Cleared Traditional

K123039 - CDI BLOOD PARAMETER MONITORING SYSTEM 500

K123039 is an FDA 510(k) clearance for CDI BLOOD PARAMETER MONITORING SYSTEM 500, manufactured by Terumo Cardiovascular Systems Corp.. The device is a Class 2 Cardiovascular device with product code DRY cleared through the Traditional 510(k) pathway after a 53-day FDA review.

K123039 · Terumo Cardiovascular Systems Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2012
Decision
53d
Days
Class 2
Risk

K123039 is an FDA 510(k) clearance for the CDI BLOOD PARAMETER MONITORING SYSTEM 500. Classified as Monitor, Blood-gas, On-line, Cardiopulmonary Bypass (product code DRY), Class II - Special Controls.

Submitted by Terumo Cardiovascular Systems Corp. (Ann Arbor, US). The FDA issued a Cleared decision on November 20, 2012 after a review of 53 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Terumo Cardiovascular Systems Corp. devices

FDA 510(k) Submission Details - K123039

510(k) Number K123039 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2012
Decision Date November 20, 2012
Days to Decision 53 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 125d · This submission: 53d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRY Device Classification - Class 2, Special Controls

Product Code DRY Monitor, Blood-gas, On-line, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRY Monitor, Blood-gas, On-line, Cardiopulmonary Bypass

All 34
Devices cleared under the same product code (DRY) and FDA review panel - the closest regulatory comparables to K123039.
Quantum Workstation
K163657 · Spectrum Medical , Ltd. · Jan 2017
TRI-OPTIC MEASUREMENT CELL
K133157 · Medtronic, Inc. · Oct 2014
CDI BLOOD PARAMETER MONITORING SYSTEM 500
K133658 · Terumo Cardiovascular Systems Corp. · Jul 2014
M4 MONITOR
K110957 · Spectrum Medical, Llp · May 2011
B-CARE5 (B-CARE5 SENSOR MODULE, VENOUS SENSOR, HOLDER FOR MEASURING HEAD)
K103168 · Sorin Group Deutschland GmbH · Jan 2011
M3 MONITOR
K091908 · Spectrum Medical , Ltd. · Jul 2009